Syra Health Corp. (SYRA)

OTCMKTS · Delayed Price · Currency is USD
0.0751
-0.0002 (-0.27%)
Aug 8, 2025, 3:36 PM EDT

Accolade Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1714---
Market Cap Growth
-76.82%-49.59%----
Enterprise Value
-1517---
Last Close Price
0.090.411.02---
PS Ratio
0.180.892.56---
PB Ratio
0.602.483.52---
P/TBV Ratio
0.602.483.52---
EV/Sales Ratio
-0.633.01---
Debt / Equity Ratio
0.050.160.061.32-47.97-0.72
Debt / EBITDA Ratio
----11.86-
Asset Turnover
1.961.861.523.935.22-
Quick Ratio
2.725.014.850.870.850.42
Current Ratio
2.885.475.250.920.850.42
Return on Equity (ROE)
-94.29%-109.09%-124.42%-602.65%--
Return on Assets (ROA)
-42.21%-54.71%-49.84%-91.44%-0.76%-
Return on Capital (ROIC)
-56.64%-61.99%-61.11%-131.88%-1.23%-
Earnings Yield
-188.93%-52.73%-20.78%---
FCF Yield
-134.25%-41.28%-19.62%---
Buyback Yield / Dilution
-63.02%-54.81%59.02%13.44%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.